US EditionPublished • loading... • Updated
Multiple Sclerosis Explained: Symptoms, Risk Factors & How It’s Treated
Multiple sclerosis affects 2.9 million worldwide and requires early diagnosis and disease-modifying therapies to prevent long-term disability, experts say.
- Multiple sclerosis , an autoimmune disorder, damages myelin in the brain and spinal cord, affecting an estimated 2.9 million people worldwide, HealthDay News reported Monday, Nov. 10, 2025.
- Risk factors include family history and more than 200 genetic contributors plus Epstein-Barr virus, low vitamin D, low UV exposure, childhood obesity and tobacco use.
- Patients commonly present with vision loss, double vision, facial droop, slurred speech, dizziness, limb weakness, fine-motor problems, Lhermitte's sign, and relapsing‑remitting MS develops symptoms over days improving in weeks to months.
- Treatment for MS works on two fronts: steroids given by IV infusion over three to five days address active inflammation, while disease‑modifying therapies approved by the U.S. Food and Drug Administration prevent new damage.
- Despite treatment advances, many people still need multidisciplinary care teams for ongoing symptoms, while fewer options exist for secondary and primary progressive MS, with Ocrevus as the only FDA-approved medication.
Insights by Ground AI
23 Articles
23 Articles
The Killeen Daily Herald+20 Reposted by 20 other sources
Multiple Sclerosis Explained: Symptoms, Risk Factors & How It’s Treated
MONDAY, Nov. 10, 2025 (HealthDay News) — Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million people estimated to be living with the disease worldwide.
Coverage Details
Total News Sources23
Leaning Left4Leaning Right2Center7Last UpdatedBias Distribution54% Center
Bias Distribution
- 54% of the sources are Center
54% Center
L 31%
C 54%
15%
Factuality
To view factuality data please Upgrade to Premium
